Immusoft

About Immusoft

Immusoft is a biotechnology company specializing in developing B cells as biofactories for therapeutic protein delivery. Their Immune System Programming (ISP) approach programs a patient’s B cells to become plasma cells that produce personalized protein therapeutics, with the aim of delivering durable therapies in the clinic. The company emphasizes translating this technology into auto-immune and other disease applications, and is based in Seattle, Washington. Immusoft positions itself as a world leader in this novel cell-based therapeutic paradigm.